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Abstract Oxidative damage to apolipoprotein A-I that occurs 
in vivo commonly involves methionine oxidation, and is 
accompanied by alterations in structure, lipid association, and 
cholesterol efflux function. We have used the enzyme peptide 
methionine sulfoxide reductase (PMSR) to reverse this damage, 
and shown by a variety of criteria that enzyme treatment restores 
the primary, secondary, and tertiary structure and lipid 
association characteristic of the native unoxidized protein. 
Lipid-associated as well as lipid-free apolipoprotein A-I reacts 
with PMSR, suggesting that enzymatic reduction of oxidized 
apolipoprotein A-! in high density lipoproteins can result in 
restoration of biological activity and the ability to promote 
cholesterol efflux from cells. 
© 1998 Federation of European Biochemical Societies. 
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I. Introduction 
Serum levels of high density lipoproteins (HDL) inversely 
correlate with the risk of coronary heart disease [1], and the 
protective ffect of HDL against atherosclerosis is thought to 
be due to its ability to mediate cholesterol efflux from cells in 
the process of reverse cholesterol transport [2]. Apolipopro- 
tein (apo) A-1 is the major protein constituent of HDL, com- 
prising about 70% of the total HDL protein. Both lipid-bound 
and lipid-free forms of apo A-I play important roles in this 
process [3]. Two of the three methionines (Met-112 and Met- 
148) in apo A-I can readily be oxidized to methionine sulf- 
oxides by chemical oxidizing agents in vitro [4,5]. Also, there 
is evidence for direct reduction of lipoprotein lipid hydroper- 
oxides by apo A-I, with conversion of Met-112 and Met-148 
to methionine sulfoxides [6,7]. Both the oxidized and unoxi- 
dized forms of apo A-I occur in vivo, and in fresh plasma 
samples the ratio oxidized/unoxidized apo A-I exhibits con- 
siderable interindividual variability [4]. Methionine oxidation 
can alter the ability of the apolipoprotein to associate with 
lipid [4,5], and oxidized apolipoprotein exhibits structural al- 
terations as detected by circular dichroism spectroscopy and 
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proteolytic susceptibility [5,8]. Recently, it has been shown 
that cellular cholesterol efflux mediated by HDL depends 
upon the ratio of unoxidized/oxidized apo A-I, and that the 
difference in the extent of efflux can reach 30% [9]. In addi- 
tion, Met-112 and Met-148 of apo A-I are located within the 
central region of the molecule which is involved in the activa- 
tion of the cholesterol esterifying enzyme lecithin:cholesterol 
acyltransferase [10]. 
Considering the deleterious effects of apo A-I oxidation and 
also that the oxidized form of apo A-I is contained in ad- 
vanced human atherosclerotic plaques [7], the search for com- 
pounds which are able selectively to reduce methionine sulf- 
oxides and to restore the structure and biological properties of 
both lipid-free and lipid-bound apo A-I will not only contrib- 
ute to our understanding of the mechanisms of lipid metabo- 
lism, but could also lead to the development of novel ap- 
proaches to the prevention and treatment of atherosclerosis 
and related cardiovascular diseases. However, previous at- 
tempts selectively to reduce methionine sulfoxides in oxidized 
apo A-I by chemical compounds, such as mercaptoethanol or 
dimethyl sulfide, were unsuccessful or incompletely character- 
ized [4]. On the other hand, it is well known that methionine 
sulfoxide residues in proteins can be readily reduced by pep- 
tide methionine sulfoxide reductase (PMSR), an enzyme 
present in microorganisms and plants [11] and practically all 
mammalian tissues [12]. PMSR has been shown to reactivate 
the oxidized inactive derivatives of al-protease inhibitor [13], 
ribosomal protein L12 [11] and Met-enkephalin [l 1]. 
In the present report we describe, for the first time, the 
ability of a mammalian PMSR overexpressed in Escherichia 
cola as well as of an enzyme contained in a crude spinach 
extract, to reduce methionine sulfoxides in the oxidized apo 
A-I and in this way to restore the structure and function of 
this apolipoprotein. 
2. Materials and methods 
2.1. Enzymes 
A homogeneous preparation of bovine PMSR, EC 1.8.4.6, overex- 
pressed in/£ eoli was a gift from Prof. Nathan Brot from the Hospital 
for Special Surgery affiliated with the New York Hospital and the 
Cornell University Medical College, New York, NY, USA, and pro- 
vided as a solution in 25 mM Tris-HC1, pH 7.4 with a protein con- 
centration of 0.37 mM. Chymotrypsin (TLCK treated, EC 3.4.21.1, 
60.6 U/mg) was purchased from Fluka (Buchs, Switzerland). Cell-free 
spinach S-30 extract was prepared as described by Brot et al. [11] and 
filtered (0.22 lam filter). 
2.2. Apolipoproteins 
Apo A-I was isolated and purified as previously described [14] by 
delipidation and subsequent gel filtration and ion-exchange chroma- 
tography of HDL obtained from pooled human serum by differential 
ultracentrifugation, u oxidized and oxidized apo A-! forms were iso- 
lated from the initial apo A-I preparation by preparative HPLC using 
a BioCAD/SPRINT System from PerSeptive Biosystems (Cambridge, 
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MA, USA), a Vydac C-18 column (22 minx250 mm) and a two- 
solvent system: A, trifluoroacetic acid/water (1:1000, v/v); B, tri- 
fluoroacetic acid/acetonitrile/water (1:900:100, v/v). The column was 
heated to 50°C in a water bath and proteins were eluted at a flow rate 
of 15 ml/min with 2849%, 49-53% and 53 73% gradient steps of 
solvent B over 12, 9 and 12 min, respectively. Then the content of 
solvent B was increased to 100% over 3 min, and finally decreased to 
28% over 2 min. Peaks were identified by SDS-PAGE (12.5% acryl- 
amide) using the standard Laemmli system [15] and by analytical 
HPLC (see below). Fractions containing apo A-I were frozen by 
liquid nitrogen and lyophilized. To verify that the isolation procedure 
did not contribute to the observed variation in the proportion of 
oxidized apo A-I, two samples were isolated from the same batch of 
pooled serum and found to have the same fractional oxidation (6% 
and 7%). Also, repetition of the delipidation and chromatography 
steps on a sample of purified apo A-I did not result in a change in 
the fractional oxidation. Naturally occurring apo A-Ion, and apo A-I,,~ 
obtained from unoxidized protein by oxidation with hydrogen perox- 
ide, have the same primary structure and contain two methionine 
sulfoxide groups at Met-ll2 and Met-148 [4], so in the text we use 
the term ~oxidized' to designate both these species, while the terms 
'unoxidized' and ~reduced' are used for naturally occurring apo A- 
L~ ...... and for apo A-I obtained by reduction of the oxidized protein 
using PMSR, 
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Fig. 1. Analytical reversed-phase HPLC profiles of initial apo A-1 
(A), apo A-l,~,,~,x isolated from initial apo A-I by preparative HPCL 
(B), apo A-l,,x obtained by treatment of apo A-I,mox with hydrogen 
peroxide for 15 min and subsequent isolation by preparative HPLC 
(C), apo A-I,,x after incubation with PMSR for 60 min (D) and apo 
A-Ir,,d isolated by HPLC (E). Retention times (in minutes) are 
shown above each peak. 
DTT concentration (13 26 mM) did not significantly increase 
the final yield of reduced protein. When using the spinach 
extract, the reaction had a linear relationship between activity 
and amount of extract but maximum yield of reduced protein 
also did not exceed 3540%. The reasons for the lack of a 
more complete conversion of apo A-Iox to apo A-Ir~d by 
PMSR are not clear. Apo A-bed protein formed as a result 
of enzymatic reduction was isolated as a homogeneous prep- 
aration (Fig. 1E), having the same electrophoretic mobility as 
apo A-I ....... on SDS-PAGE (Fig. 2A, lane 3) and on non- 
denaturing PAGE (data not shown). This material was used 
in further studies. Reoxidation of the isolated apo A-Irma using 
hydrogen peroxide resulted in the formation of oxidized pro- 
tein form with a chromatographic pattern similar that for apo 
A-lox (data not shown). 
Matrix-assisted laser desorption mass spectrometry revealed 
that apo A-I,,x was 32 mass units greater than the initial apo 
A-I ....... and apo A-Ir,,d. Therefore, under the conditions used 
in this study, both of the labile methionine residues Met-112 
and Met-148 are oxidized by H202, consistent with previously 
reported data [4], and both are reduced by PMSR. CNBr 
cleaves proteins by conversion of methionine to homoserine 
lactone with concomitant peptide bond cleavage, but methio- 
nine sulfoxides are resistant o reaction. We used CNBR to 
probe for the presence of methionine and methionine sulfox- 
ide residues in apo A-I preparations. The results of CNBr 
digestion of unoxidized, oxidized and reduced apo A-I are 
shown in Fig. 2B (lanes 1, 2 and 3, respectively). Unoxidized 
and reduced apo A-I had the same electrophoretic pattern and 
were almost completely by CNBr while apo A-Iox was much 
more resistant as previously reported by Anantharamaiah et 
al. [5]. These results indicate that unoxidized and reduced apo 
A 
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Fig. 2. SDS-PAGE analysis of unoxidized, oxidized and reduced 
apo A-I and digestion with chymotrypsin and CNBr. Undigested 
apo A-I (A) or apo A-I digested with CNBr (B) or chymotrypsin 
(C) were analyzed by 12.5% (A) or by 15% (B and C) acrylamide 
SDS-PAGE and detected by staining with Coomassie blue R-250. 
Lane 1, apo A-I ....... ; lane 2, apo A-Iox; lane 3, apo A-Ir~,d. The po- 
sitions and molecular masses of protein standards are indicated on 
the left of the gels. 
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Fig. 3. Far-UV circular dichroism spectra nd temperature-induced 
unfolding of unoxidized, oxidized, and reduced apo A-I. Circular di- 
chroic spectra were measured for unoxidized (A), oxidized (B) and 
reduced (C) apo A-1 (7.2 btM) with (dotted line) and without (solid 
line) 2.3 mM DHPC or in the presence of 4 M urea (dashed line) 
in 10 mM ammonium bicarbonate, 0.005% sodium azide, pH 7.8; 
in a 1 mm path-length cell at 25°C, with 1 nm bandwidth and 1.0 s 
averaging per point. Temperature-induced unfolding data (D) were 
collected in a temperature ange of 25 95°C at 222 nm on a solu- 
tion of 7.2 laM (0.05-0.2 mg/ml) apo A-I in 10 mM ammonium bi- 
carbonate, 0.005% sodium azide, pH 7.8; in a 1 mm path-length 
cell; with 1 nm bandwidth, l°C temperature increment, and 5.0 s 
averaging per point. 
A-I contain the reduced methionine residues in contrast with 
apo A-Io×. This together with the mass spectrometric and 
HPLC data confirm that the reduction of apo A-Iox by 
PMSR results in the restoration of the primary apo A-I struc- 
ture damaged by the oxidative modification induced by hy- 
drogen peroxide. 
To examine whether the reduction of apo A-Io× using 
PMSR restores protein secondary structural features, CD 
spectra were measured for unoxidized, oxidized and reduced 
apo A-I (Fig. 3). The CD spectra of all three proteins were 
characterized by double minima at ,~ 208 nm and ,~ 222 nm 
and a maximum about 195 nm, features that are typical of 
proteins with a high helical content. The spectrum of apo A- 
I,,x (Fig. 3B) was considerably less intense than that of the 
unoxidized form (Fig. 3A), indicating a reduction of apo A-I 
helical content upon oxidation, consistent with previous re- 
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ports (Table 1). In contrast, in the presence of 4 M urea the 
denatured proteins exhibited similar CD spectra indicative of 
a lack of any defined secondary structure. Reduction of the 
methionine sulfoxide residues in apo Alox with PMSR com- 
pletely restored the CD spectrum (Fig. 3C) and calculated 
fractional helicity values (Table 1) characteristic of the unoxi- 
dized protein. 
To examine whether the reduction of apo A-I,,× by PMSR 
also restores protein tertiary structural features, the temper- 
ature-induced unfolding of unoxidized, oxidized and reduced 
apo A-I was observed by CD spectroscopy (Fig. 3D). Apo A- 
I . . . . . .  was characterized by a weakly cooperative unfolding 
with midpoint emperature 65 + 2°C indicative of a globular, 
folded structure [17], while apo A-lox did not exhibit any 
cooperative unfolding transition, suggestive of a largely un- 
folded structure. Reduction of A-Iox with PMSR completely 
restored the characteristic thermal denaturation of the native 
unoxidized protein (Fig. 3E). 
We carried out also a comparative study of the protease 
susceptibility of unoxidized and oxidized apo A-I using chy- 
motrypsin. Oxidation of the two methionine residues of apo 
A-lox results in a dramatic increase in the protease suscepti- 
bility (Fig. 2C, lane 2) in comparison with the unoxidized 
form (Fig. 2C, lane 1). The oxidized protein is rapidly and 
completely digested to small fragments, consistent with the 
largely unfolded structure suggested by the thermal denatura- 
tion data. A similar increase of apo A-I protease susceptibility 
upon oxidation of the methionine residues 112 and 148 to 
sulfoxides has been recently reported [8]. Again, the behavior 
of the native unoxidized protein was restored upon reduction 
of the methionine sulfoxide with PMSR, and apo A-I,.< is 
essentially completely resistant o chymotrypsin (Fig. 2C, 
lane 3). This together with the CD results confirm that the 
reduction of A-Iox by PMSR results in restoration of the 
secondary and tertiary apo A-I structures damaged by the 
oxidative modification i duced by hydrogen peroxide. 
Apo A-I associates with lipids to form HDL particles. A 
conformational change in apo A-I has been correlated with 
lipid association [18]. To examine this conformational change 
and its dependence on the apo A-I oxidation state, we used 
the short-chain lipid DHPC as a convenient model lipid to 
study lipid-bound apo A-I structural features. CD spectra of 
apo A-I,,,,,,x taken in the presence of 2.3 mM DHPC indicate a
substantial increase in helical content relative to the lipid-free 
form (Fig. 3A, Table 1), consistent with previous tudies using 
another lipid system [5,17]. The very high helical content of 
lipid-associated apo A-I calculated by the method of Chen et 
al. [16] is supported by the recently determined crystal struc- 
ture of a large fragment of apo A-I ....... (residues 44-243) 
believed to be in the lipid-associated state, which is essentially 
completely helical [19]. In contrast o previous tudy using a 
different lipid [5], we observed a small but significant increase 
in the helical content of apo A-I,,x upon lipid association (Fig. 
Table 1 
Apparent fractional helical content of unoxidized, oxidized and reduced apo A-l, in the absence or presence of lipids 
Protein This study Previous tudies 
Buffer alone +DHPC Buffer alone +POPC +DMPC Reference 
Apo A-I . . . . . .  66 81 68 82 [17] 
Apo A-l,,x 37 48 30 29 [5] 
Apo A-Ii.ed 68 82 
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3B, Table 1). After reduction of apo A-fox with PMSR, the 
CD spectra (Fig. 3C) and calculated helical content (Table 1) 
of apo A-Ir~d in the presence of DHPC were indistinguishable 
from those of apo A-I ........ indicating that methionine sulfox- 
ide reduction restores the native lipid-dependent conforma- 
tional change. The addition of DHPC (up to final concentra- 
tion of 2.3 raM) to the reaction mixture containing apo A-I,,× 
and PMSR did not affect the reaction rate of the yield of the 
apo A-I,.,,d (data not shown). This fact strongly suggests that 
apo A-I,,x in HDL can be also reduced by PMSR and by this 
way restored its ability to promote cholesterol efflux from 
cells, a crucial step in the process of reverse cholesterol trans- 
port. 
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